2023 annual financial data
Aspire Biopharma Holdings 2023 Operating margin
Aspire Biopharma Holdings 2023 operating margin with verified reported values.
Direct answer
Operating margin was Not calculable.
Operating income was -1,340,000 USD and net income was 4,464,000 USD.
Operating cash flow was -653,107 USD.
Get free Aspire Biopharma Holdings email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 0 USD
- Operating income
- -1,340,000 USD
- Net income
- 4,464,000 USD
- Operating cash flow
- -653,107 USD